Sun Pharmaceuticals Ltd. is India's largest drugmaker according to market value, but shares have declined almost 3 percent. This drop is a result of Sun Pharma's patent litigation settlement with Pfizer Inc. Sun Pharma was found to have sold Pfizer's heartburn drug Protonix without authorization and has agreed to pay $550 million as a result. Read the full story.